美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=ZEPBOUND"
符合检索条件的记录共 24 条
共 2 页，当前第 1 页
下一页 最后一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
ZEPBOUND (AUTOINJECTOR) 217806 001 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 2.5MG/0.5ML (2.5MG/0.5ML) Yes Yes 2023/11/08 2023/11/08 ELI LILLY AND CO Prescription
ZEPBOUND (AUTOINJECTOR) 217806 002 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 5MG/0.5ML (5MG/0.5ML) Yes Yes 2023/11/08 2023/11/08 ELI LILLY AND CO Prescription
ZEPBOUND (AUTOINJECTOR) 217806 003 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 7.5MG/0.5ML (7.5MG/0.5ML) Yes Yes 2023/11/08 2023/11/08 ELI LILLY AND CO Prescription
ZEPBOUND (AUTOINJECTOR) 217806 004 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/0.5ML (10MG/0.5ML) Yes Yes 2023/11/08 2023/11/08 ELI LILLY AND CO Prescription
ZEPBOUND (AUTOINJECTOR) 217806 005 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 12.5MG/0.5ML (12.5MG/0.5ML) Yes Yes 2023/11/08 2023/11/08 ELI LILLY AND CO Prescription
ZEPBOUND (AUTOINJECTOR) 217806 006 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 15MG/0.5ML (15MG/0.5ML) Yes Yes 2023/11/08 2023/11/08 ELI LILLY AND CO Prescription
ZEPBOUND 217806 007 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 2.5MG/0.5ML (2.5MG/0.5ML) Yes Yes 2023/11/08 2024/03/28 ELI LILLY AND CO Prescription
ZEPBOUND 217806 008 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 5MG/0.5ML (5MG/0.5ML) Yes Yes 2023/11/08 2024/03/28 ELI LILLY AND CO Prescription
ZEPBOUND 217806 009 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 7.5MG/0.5ML (7.5MG/0.5ML) Yes Yes 2023/11/08 2024/03/28 ELI LILLY AND CO Prescription
ZEPBOUND 217806 010 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/0.5ML (10MG/0.5ML) Yes Yes 2023/11/08 2024/03/28 ELI LILLY AND CO Prescription
ZEPBOUND 217806 011 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 12.5MG/0.5ML (12.5MG/0.5ML) Yes Yes 2023/11/08 2024/03/28 ELI LILLY AND CO Prescription
ZEPBOUND 217806 012 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 15MG/0.5ML (15MG/0.5ML) Yes Yes 2023/11/08 2024/03/28 ELI LILLY AND CO Prescription
ZEPBOUND 217806 013 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/2.4ML (4.17MG/ML) Yes Yes 2023/11/08 2026/01/07 ELI LILLY AND CO Prescription
ZEPBOUND 217806 014 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 20MG/2.4ML (8.33MG/ML) Yes Yes 2023/11/08 2026/01/07 ELI LILLY AND CO Prescription
ZEPBOUND 217806 015 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 30MG/2.4ML (12.5MG/ML) Yes Yes 2023/11/08 2026/01/07 ELI LILLY AND CO Prescription
ZEPBOUND 217806 016 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 40MG/2.4ML (16.7MG/ML) Yes Yes 2023/11/08 2026/01/07 ELI LILLY AND CO Prescription
ZEPBOUND 217806 017 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 50MG/2.4ML (20.8MG/ML) Yes Yes 2023/11/08 2026/01/07 ELI LILLY AND CO Prescription
ZEPBOUND 217806 018 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 60MG/2.4ML (25MG/ML) Yes Yes 2023/11/08 2026/01/07 ELI LILLY AND CO Prescription
ZEPBOUND KWIKPEN 217806 019 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/2.4ML (4.17MG/ML) Yes Yes 2023/11/08 2026/01/20 ELI LILLY AND CO Prescription
ZEPBOUND KWIKPEN 217806 020 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 20MG/2.4ML (8.33MG/ML) Yes Yes 2023/11/08 2026/01/20 ELI LILLY AND CO Prescription
药品名称，活性成分，申请号搜索 高级检索
©2006-2026 DrugFuture->U.S. FDA Drugs Database